5VB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nykode Therapeutics ASA

Watchlist Manager

Watchlist

Price: 0.3815 EUR -1.17% Market Closed

Market Cap: €756.2m

N	Nykode Therapeutics ASA XMUN:5VB	NO
S	Sonic Automotive Inc F:SA8A	US
F	Fuxing China Group Ltd SGX:AWK	CN
	Hot Chili Ltd F:CHC1	AU
D	Daiwa Securities Group Inc XMUN:DSE	JP
S	Suedwestdeutsche Salzwerke AG SWB:SSH	DE
	Odfjell SE F:O7F1	NO
	Park24 Co Ltd F:5FJ	JP
U	Ucb SA F:UNC	BE
	Searchlight Resources Inc F:2CC	CA
	North West Company Inc F:3NW	CA

Profitability Summary

Nykode Therapeutics ASA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-675%

Low Net Margin

Negative 3Y Average Net Margin

-423%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-948%

Negative ROE

-11%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-120%

ROIC is Increasing

-512% > -56%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.